RAFFA WEALTH MANAGEMENT, LLC’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.22K Hold
28
﹤0.01% 807
2026
Q1
$2.1K Hold
28
﹤0.01% 737
2025
Q4
$2.21K Hold
28
﹤0.01% 716
2025
Q3
$1.83K Hold
28
﹤0.01% 736
2025
Q2
$1.11K Hold
28
﹤0.01% 842
2025
Q1
$845 Hold
28
﹤0.01% 870
2024
Q4
$979 Hold
28
﹤0.01% 874
2024
Q3
$1.12K Hold
28
﹤0.01% 821
2024
Q2
$1.33K Hold
28
﹤0.01% 818
2024
Q1
$1.21K Buy
+28
New +$1.33K ﹤0.01% 846
2023
Q3
$1.27K Buy
+28
New +$1.16K ﹤0.01% 715
2022
Q4
$1.06K Hold
28
﹤0.01% 764
2022
Q3
$1.24K Buy
+28
New +$1.18K ﹤0.01% 731
2021
Q4
$852 Hold
28
﹤0.01% 928
2021
Q3
$939 Hold
28
﹤0.01% 840
2021
Q2
$1.12K Buy
+28
New +$1.1K ﹤0.01% 788
2020
Q4
$1.02K Buy
+18
New +$897 ﹤0.01% 741
2020
Q2
$1.06K Hold
18
﹤0.01% 648
2020
Q1
$851 Buy
+18
New +$1K ﹤0.01% 638
2019
Q3
$1.08K Buy
+18
New +$1.17K ﹤0.01% 569
2018
Q1
$793 Buy
+18
New +$914 ﹤0.01% 690
2017
Q1
$1.17K Buy
+29
New +$1.3K ﹤0.01% 313
2016
Q3
$1.06K Buy
+29
New +$907 ﹤0.01% 394
2016
Q1
$1.18K Hold
29
﹤0.01% 357
2015
Q4
$1.8K Buy
+29
New +$1.56K ﹤0.01% 279

Other funds holding IONS

RAFFA WEALTH MANAGEMENT, LLC's IONS Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 28 shares worth $2.22K. The position accounts for ﹤0.01% of the portfolio, ranked #807.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in IONS in Q4 2015 and has held it in 25 quarters since. 94 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • RAFFA WEALTH MANAGEMENT, LLC held 28 shares of Ionis Pharmaceuticals worth $2.22K as of Q2 2026.
  • RAFFA WEALTH MANAGEMENT, LLC left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #807 holding.
  • RAFFA WEALTH MANAGEMENT, LLC first reported a position in Ionis Pharmaceuticals in Q4 2015 and has held it in 25 quarters since.
  • 94 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.